The results revealed an upregulation of genes encoding cAMP-dependent catalytic α and γ protein subunits in lung cancer cells treated with CEA (Fig. 5a), indicating a potential increase in intracellular cAMP concentration and subsequent activation of PKA. Here, CEACAM5 is linked to lung carcinoma.